$2 / month

Comment and reply across TML.

Start or manage membership

Most pulsed

Latest from other desks

tml.the modern leap
Health / Public Health

FDA Classifies Cardinal Health Correction As Class I

Some Presource procedure kits on hospital shelves contain BD Alaris infusion sets that can deliver too much medication, too little, or none at all, and the FDA says the correction has to happen before the kits are used again.

TML Health DeskNov 18, 7:52 AM ET · 2 min read

Edited and fact-checked by Stephen Sprague

Staff Sgts. Caleb Gibson and Erick Bartels check patient monitors shelved at Joint Base Andrews, Maryland (archive). Photo: U.S. Air Force photo by Val Gempis, public domain, via Wikimedia Commons.
Summary

The correction is a work order, not a shipment recall. Hospitals keep the kits, pull the recalled Alaris sets out of them, and label the front of every pack before it reaches a procedure room.

Tap a passage. React to the part that matters.

The FDA classified Cardinal Health's Presource kit correction as Class I, its most serious recall category, on November 16. The kits may contain BD Alaris Pump Infusion Sets that BD and CareFusion 303 already recalled, and the agency's instruction to hospitals is to correct each kit before it reaches a patient, because a device in this category may cause serious injury or death if it's used without the correction.

A Presource kit is a sealed pack holding the instruments, dressings and components for a single surgical or medical procedure, which means the recalled set sits hidden inside packaging a supply room counts as ready. The failure mode is in the pump's behavior once that set is loaded. It can deliver too little medication, too much, or nothing at all, and the FDA says the malfunction may lead to severe adverse events.

Dosing errors land hardest where the doses are smallest. The agency singles out neonates, pediatric patients and critically ill patients as the groups where an infusion failure carries the most severe consequences, and those are the patients whose medication arrives by pump around the clock in intensive care units and surgical suites.

Cardinal Health's correction letter went to affected customers on September 24, six weeks before the classification, and it reads like a supply-room work order. Staff are to locate and quarantine the affected kits, alert the clinicians who open them, and stick a warning label on the front of every kit instructing clinicians to remove and discard the recalled sets inside. Extra labels ship on request, and distributors that moved kits downstream are told to notify their customers.

The timeline shows a problem the system caught in layers. BD's underlying infusion set recall came first, the FDA issued an Early Alert on October 20, and the Class I classification followed on November 16. As of August 19, BD had not reported any serious injuries or deaths tied to the issue. Facilities with questions can call Cardinal Health Quality Systems at (800) 292-9332, and adverse events go to the FDA's MedWatch program.

What happens at each hospital now is inventory work, and the FDA's communication carries the full list of affected devices for the staff doing it. Every Presource kit already sitting on a shelf has to be matched against that list, quarantined when it matches, and labeled before it returns to circulation. A kit that skips the check carries the recalled set into the procedure room inside sealed packaging, which is the exact failure the warning label exists to interrupt.

Sources

The conversation

A little more perspective.

Reading is free. Verified members can comment and reply for $2 a month.

The conversation.

Loading comments…

Keep your curiosity going.

Some links here are affiliate links. If you buy through one, we might make a commission — it never changes what you pay. As an Amazon Associate I earn from qualifying purchases.